The IPAK COVID-19 get America back-to-work plan :

The IPAK COVID-19 get America back-to-work plan :

(formulated by Dr James Lyons-Weiler from IPAK with minor modifications and clarifications by me).

It’s not an understatement to say that right now we are in an unprecedented time. We are in the midst of a global pandemic, economies are tottering, jobless claims rates are at an all time high and things seem bleak. They don’t have to be that way.

It seems as if the solution to the COVID-19 pandemic has been to play catch up. The decision-makers seemed to be faced with only two options:

Destroy the economy or Risk the health of their community.

I propose a third option. This option is largely based in the proposal being championed by Dr. James Lyons-Weiler of IPAK. I make use of this model with a couple of important additions and clarifications.

The basis of the proposal is :

1. Voluntary, private in-home antibody testing.

2. Those who are immune return to work

3. Prophylactic anti-viral medicines or nutraceuticals for at-risk groups.

4. Those who are most vulnerable to severe disease stay quarantined.

This will allow for the economy to get back on some solid footing while providing a means for minimizing the spread of disease.

Here’s how it works:

TESTING: It must be voluntary. It is inconsistent with principles of liberty to force testing. There are several ethical ramifications with ordering mandatory testing. Therefore it must be voluntary.

It also must make use of the rapid, point-of-care antibody testing using validated non-CDC lateral assay antibody tests (like an at-home pregnancy test). There are several companies which are releasing antibody testing. This would be the preferred option to the PCR testing for a few reasons. First it is easier to administer. A finger or heel prick is all that is needed in most cases. Second, its fast. Rather that the 2-10 day turn around for the PCR test that has been commonly used, the antibody test can result can read in as little as 15 minutes.

In addition, the validity of PCR testing has been seriously called in to questions. There is strong evidence that the CDC PCR test has unacceptably high rates of false negatives. (1,2)

SEGREGATION: Next we must allow people to group themselves according to age, risk, exposure and test results. This grouping, again, must be voluntary. The groups would be as follows: (modified from IPAK back to work protocol)

Group A) High risk – older than 60, diabetes, obesity, heart disease or other chronic disease. These people should stay self-quarantined as much as possible. If they test positive for IgG response they can consider limited social contact.

Group B) Tested individuals with no known medical comorbidities:

(1) For all symptomatics: Two negative IgM tests 1 week apart, back to work.*

(2) For people w/past diagnoses: One negative IgM test after being asymptomatic for at least 5 days.

(3) Asymptomatics who have been in contact w/a COVID‐19 case, two negative IgM results 1 week apart.

(4) Asymptomatics never in contact with a COVID‐19 case, never tested, two negative results, 5 days apart.

(5) I URGENTLY RECOMMEND prophylactic antiviral use starting 1 day before back to work.

  • * A positive IgG test would indicate immunity to SARS-COV-2.

SymptomaticAsymptomaticBack to work
At risk – age, comorbiditiesSelf – quarantineSelf – quarantineNo
+ Past diagnosis2 negative IgM tests 1 week apart1 negative test if after no symptoms for 5 daysYes
+ Contact2 Negative IgM tests 1 week apart2 negative IgM tests 1 week apartYes
– Contact2 Negative IgM tests 1 week apart2 negative IgM tests 5 days apartYes
Back to Work Graphic

TESTING LOCATION: Testing should be done at home. This will ensure privacy and safety. We do not want those who are sick congregating at central testing centers and increasing the chance of viral transmission. A medical could prick the patients finger and add the testing solution and then leave the test in the hands of the patient to be read in the proper time frame.

REPORTING: Again, this must be voluntary. If a person want to share this information with an employer, family member, physician, insurance company or other party they are at liberty to do so. There must be no requirement for reporting of result. – Yes. We will have to trust one another.

TREATMENT: There are a number of treatment options. I will not discuss each if these here but the aims are to decrease viral load and improve the body’s ability to fight the virus. There are prescription medications which are relatively safe and nutraceuticals and other treatments that are likely effective. I wouldn’t look for only treatments that are FDA approved since there have been few significant studies done on treating COVID-19. Some of these treatments can be found here.

Let’s not make to cure worse than the disease. – Dr. TL Hutton

  1. https://www.fda.gov/media/134920/download

2. https://www.medrxiv.org/content/10.1101/2020.02.11.20021493v2.full.pdf

No Comments

Leave a Reply

%d bloggers like this: